Browse studies

Find your next paid study

3,080 recruiting studies matching your filters

Six Versus Twelve Month SurveillAnce Following Resection of Nonpedunculated ColorectaL Polyps 20-50 mm IN Size Without High Grade Dysplasia (HGD)

The study will compare the use of a 6-month follow-up vs a 12-month follow-up after the removal of a large non-pedunculated polyp 20-50mm in size and without h…

Colon CancerColon PolypAdenoma+3 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Indiana UniversityNCT07198945

Phase 1

A Phase 1 Dose Escalation Trial to Determine the Safety, Tolerance, Maximum Tolerated Dose, and Preliminary Antineoplastic Activity of the IKS04 Regimen Targeting CA242

This study will evaluate the safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of the IKS04 Regimen and identify…

Colorectal CancerGastro Esophageal Junctional CancerGastric Cancer (GC)+5 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Iksuda Therapeutics Ltd.NCT07738939

Phase 1

A Phase IB, Single Dose, Open-Label, Dose-escalation Study to Investigate the Safety and Imaging Characteristics of Pemefolacianine for Intraoperative Molecular Imaging of Lung Cancer

The aim of this Phase 1b study is to investigate the safety and fluorescence signal of a single dose of Pemefolacianine for Injection, a novel fluorescence ima…

Lung Cancer (Locally Advanced or Metastatic)

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Sunil SinghalNCT07772895

Phase 2

Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)

To find out if giving blinatumomab as injections under the skin and olverembatinib can help to control the disease in patients with Ph-positive ALL.

Phase II Clinical TrialBlinatumomabOlverembatinib+2 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT07178912

Antibiotic Concentrations After MassivE Transfusion (ACME) Study

Combat and civilian trauma frequently result in open wounds that are at risk for infection. Data from the Department of Defense Trauma Registry demonstrate tha…

Adverse Effects in the Therapeutic Use of Other and Unspecified Agents Affecting Blood Constituents

Estimated

~$10 – $750

Actual pay is set by the research site.

Brooke Army Medical CenterNCT06699901

Phase 2

SMART-PANC: SMAD4 Tailored Neoadjuvant Therapy for Pancreatic Cancer, A Phase ll Non-Randomized, Single Center Pilot Study

This phase II trial tests the impact of using SMAD4-mutant status to personalize chemotherapy in treating patients with pancreatic ductal adenocarcinoma (PDAC)…

Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Northwestern UniversityNCT07748611

Observational

Exercise and Cognition in Middle-Aged Adults With Histories of Childhood Trauma and Cognitive Complaints

This study aims to identify and compare the effects of acute and chronic exercise interventions on cognition in middle-aged adults with cognitive complaints an…

Adverse Childhood Experiences

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Texas at AustinNCT05972265

Phase 2

Phase II Study Evaluating NALIRIFOX Versus Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma

This is a single-center, open-label, randomized Phase 2 trial to evaluate the efficacy of NALIRIFOX (Arm 1) vs mGAP (Arm 2) in previously untreated patients wi…

Metastatic Pancreatic AdenocarcinomaLocally Advanced Pancreatic Adenocarcinoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Medical University of South CarolinaNCT07076212

Observational

Probing the Neurophysiological Mechanisms Underlying Sex-specific Testosterone-mood Relationships During Puberty: A Randomized Controlled Trial Using a Smartphone-based Training Program

Starting at puberty, female adolescents are nearly three-times more likely to develop internalizing disorders, like depression, while male adolescents are two-…

Adolescent Depression

Estimated

~$10 – $750

Actual pay is set by the research site.

University of North Carolina, Chapel HillNCT06072677

Phase 4

An Assessment of Patient Position and Intravesical BCG Dwell Time

This phase IV trial studies whether there is a relationship between how a patient is positioned while receiving bacillus Calmette Guerin (BCG) within the bladd…

Non-Muscle Invasive Bladder Carcinoma

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Ohio State University Comprehensive Cancer CenterNCT07474519

Phase 1

A First-in-human, Phase I, Multi-center, Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Evidence of Antitumor Activity of IDOV-Immune in Adult Participants With Advanced Solid Tumors

This is a Phase I clinical trial evaluating an investigational treatment called IDOV-Immune, a type of oncolytic virus therapy, for adults with advanced solid …

Colorectal CancerPancreatic CancerMelanoma+13 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

ViroMissile, Inc.NCT06910657

Observational

CSP #2036 - VA Randomized Trial of Surveillance Intervals After Transurethral Resection of High-Grade Bladder Tumors (VATSIT)

CSP #2036 is a pragmatic, randomized, intent-to-treat, two-arm, parallel, multicenter CSP trial. Blinding of clinical staff and participants will not be possib…

High-Grade Early-Stage Bladder Cancer

Estimated

~$10 – $675

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT07408830